SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla’s arms complete sale of entire 51.18% stake in CQCIL

15 Nov 2023 Evaluate

Cipla’s wholly owned subsidiaries -- Cipla (EU), UK and Meditab Holdings, Mauritius, have completed the sale of entire 51.18% stake held in Cipla Quality Chemical Industries (CQCIL), Uganda on November 14, 2023 for final consideration amount of $25 million. Accordingly, CQCIL has now ceased to be a subsidiary of the company with effect from November 14, 2023.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1441.70 10.05 (0.70%)
09-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.85
Dr. Reddys Labs. 1269.80
Cipla 1441.70
Zydus Lifesciences 1159.85
Lupin 2502.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: